Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway
Teresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang · 2025
Read Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway by Teresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12727864.txt.
Description
Campbell and co-authors find in 2025 a new disease path for a rare mitochondrial illness tied to faults in a gene called FDXR. The gene's loss causes abnormal iron build up in mitochondria, but the chain of harm was unclear. They built a mouse model of the human hotspot variant.
Fat damage rose in inner mitochondrial and outer cell membranes, which made cells prone to an iron driven death called ferroptosis. A defense pathway and its target gene were disrupted in the model. A drug that switches that pathway on, already approved for another disease, eased the harm. The authors propose it as a near term treatment option.
Catalog record
| CREATOR | Teresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |